B
Biohit Oyj
OMXH:BIOBV
Biohit Oyj
OMXH:BIOBV
Price:
2.5
EUR
0.4%
Market Cap:
€37.8m
Relative Value
The Relative Value of one BIOBV stock under the Base Case scenario is 2.55 EUR. Compared to the current market price of 2.5 EUR, Biohit Oyj is Undervalued by 2%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BIOBV
Relative Value
Base Case
2.55
EUR
Undervaluation 2%
B
Multiples Across Competitors
BIOBV Competitors Multiples
Biohit Oyj Competitors
Biohit Oyj Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| FI |
B
|
Biohit Oyj
OMXH:BIOBV
|
37.8m EUR | 2.4 | 14.1 | 9.6 | 11.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
192.4B USD | 4.3 | 29.5 | 16.9 | 23.2 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
175.6B USD | 17.4 | 61.5 | 46.7 | 57.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
141.6B USD | 5.6 | 43.6 | 22.1 | 26.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
119.3B USD | 3.4 | 25.9 | 14.1 | 20.6 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.7B USD | 5.3 | 37 | 21.7 | 29.1 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
46B EUR | 2 | 21.6 | 12 | 16.9 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
49.3B USD | 11.5 | 46.6 | 33.1 | 36.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
48.5B USD | 8 | 45.2 | 24.9 | 27.2 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
47.9B USD | 2.2 | 27.3 | 10.6 | 17.9 | |
| US |
|
Resmed Inc
NYSE:RMD
|
36.9B USD | 6.9 | 24.9 | 17.6 | 19.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
